Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era
Crossref DOI link: https://doi.org/10.1136/bmjophth-2020-000696
Published Online: 2021-04-27
Published Print: 2021-04
Update policy: https://doi.org/10.1136/crossmarkpolicy
Downey, Louise
Acharya, Nachiketa
Devonport, Helen
Gale, Richard
Habib, Maged
Manjunath, Vina
Mukherjee, Rajarshi
Severn, Philip
Funding for this research was provided by:
Alimera Sciences Ltd.
License valid from 2021-04-27